✦ LIBER ✦

Utilities and disutilities for attributes of injectable treatments for type 2 diabetes

✍ Scribed by Kristina S. Boye; Louis S. Matza; Kimberly N. Walter; Kate Van Brunt; Andrew C. Palsgrove; Aodan Tynan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Utilities and disutilities for type 2 di

✍ Louis S. Matza; Kristina S. Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 264 KB

PDB37/DBI: PATIENT-REPORTED UTILITIES/DI

✍ K Secnik; LS Matza; NR Yugrin; S Mannix; J Brewster-Jordan; B Barber 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PDB45 ASSESSING UTILITIES AND DISUTILITI

✍ D Bruhn; M Gibbs; RC Jung; A Kalsekar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

UTILITIES FOR TYPE 2 DIABETES MELLITUS A

✍ Shingler, S.L.; Fordham, B.; Evans, M.; Thompson, G.; Schroeder, M.; Lloyd, A.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Investigational treatments for Type 2 di

✍ González, Claudio; Beruto, Valeria; Keller, Guillermo; Santoro, Silvina; Di Giro 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 183 KB

Physician Preferences for Extra-Glycemic

✍ Poulos, Christine; González, Juan Marcos; Lee, Lauren J.; Boye, Kristin S.; John 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 799 KB